Cutler Group LP Seelos Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$0.65 - $278.68 $32,500 - $13.9 Million	-50,000 Reduced 99.8%	100 $0
Q1 2022 Apr 14, 2022	SELL	$0.84 - $1.71 $336 - $684	-400 Reduced 0.79%	50,100 $6,000
Q4 2021 Jan 18, 2022	SELL	$1.59 - $2.38 $119,091 - $178,262	-74,900 Reduced 59.73%	50,500 $34,000
Q3 2021 Oct 26, 2021	BUY	$1.69 - $2.89 $202,800 - $346,800	120,000 Added 2222.22%	125,400 $51,000
Q2 2021 Jul 19, 2021	BUY	$2.64 - $6.32 $2,904 - $6,952	1,100 Added 25.58%	5,400 $0
Q1 2021 Apr 26, 2021	BUY	$1.35 - $4.99 $5,805 - $21,457	4,300 New	4,300 $1,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $41.6M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.